Wednesday, March 30, 2022

[ASAP] Retraction of “A DNA Nanodevice Simultaneously Activating the EGFR and Integrin for Enhancing Cytoskeletal Activity and Cancer Cell Treatment”

Nano Letters
DOI: 10.1021/acs.nanolett.2c01083


from Nano Letters: Latest Articles (ACS Publications) https://ift.tt/ZrCMWzi
via IFTTT

No comments:

Post a Comment